Literature DB >> 28821622

The replication and transcription activator of murine gammaherpesvirus 68 cooperatively enhances cytokine-activated, STAT3-mediated gene expression.

Hui-Chen Chang Foreman1, Julie Armstrong1, Alexis L Santana1, Laurie T Krug2, Nancy C Reich3.   

Abstract

Gammaherpesviruses (γHVs) have a dynamic strategy for lifelong persistence, involving productive infection, latency, and intermittent reactivation. In latency reservoirs, such as B lymphocytes, γHVs exist as viral episomes and express few viral genes. Although the ability of γHV to reactivate from latency and re-enter the lytic phase is challenging to investigate and control, it is known that the γHV replication and transcription activator (RTA) can promote lytic reactivation. In this study, we provide first evidence that RTA of murine γΗV68 (MHV68) selectively binds and enhances the activity of tyrosine-phosphorylated host STAT3. STAT3 is a transcription factor classically activated by specific tyrosine 705 phosphorylation (pTyr705-STAT3) in response to cytokine stimulation. pTyr705-STAT3 forms a dimer that avidly binds a consensus target site in the promoters of regulated genes, and our results indicate that RTA cooperatively enhances the ability of pTyr705-STAT3 to induce expression of a STAT3-responsive reporter gene. As indicated by coimmunoprecipitation, in latently infected B cells that are stimulated to reactivate MHV68, RTA bound specifically to endogenous pTyr705-STAT3. An in vitro binding assay confirmed that RTA selectively recognizes pTyr705-STAT3 and indicated that the C-terminal transactivation domain of RTA was required for enhancing STAT3-directed gene expression. The cooperation of these transcription factors may influence both viral and host genes. During MHV68 de novo infection, pTyr705-STAT3 promoted the temporal expression of ORF59, a viral replication protein. Our results demonstrate that MHV68 RTA specifically recognizes and recruits activated pTyr705-STAT3 during the lytic phase of infection.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  STAT3; gammaherpesvirus; gene expression; infection; signal transduction; tyrosine; tyrosine phosphorylation; virology

Mesh:

Substances:

Year:  2017        PMID: 28821622      PMCID: PMC5625055          DOI: 10.1074/jbc.M117.786970

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  78 in total

1.  Epstein-Barr virus-derived EBNA2 regulates STAT3 activation.

Authors:  Ryuta Muromoto; Osamu Ikeda; Kanako Okabe; Sumihito Togi; Shinya Kamitani; Masahiro Fujimuro; Shizuko Harada; Kenji Oritani; Tadashi Matsuda
Journal:  Biochem Biophys Res Commun       Date:  2008-11-24       Impact factor: 3.575

2.  Upregulation of STAT3 marks Burkitt lymphoma cells refractory to Epstein-Barr virus lytic cycle induction by HDAC inhibitors.

Authors:  Derek Daigle; Cynthia Megyola; Ayman El-Guindy; Lyn Gradoville; David Tuck; George Miller; Sumita Bhaduri-McIntosh
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

3.  Persistent activation of STAT3 by latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells.

Authors:  Almira S Punjabi; Patrick A Carroll; Lei Chen; Michael Lagunoff
Journal:  J Virol       Date:  2006-12-06       Impact factor: 5.103

4.  Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 RTA reactivates murine gammaherpesvirus 68 from latency.

Authors:  Tammy M Rickabaugh; Helen J Brown; Ting-Ting Wu; Moon Jung Song; Seungmin Hwang; Hongyu Deng; Katherine Mitsouras; Ren Sun
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

5.  STAT3 nuclear import is independent of tyrosine phosphorylation and mediated by importin-alpha3.

Authors:  Ling Liu; Kevin M McBride; Nancy C Reich
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-26       Impact factor: 11.205

Review 6.  STAT3 as a therapeutic target for Epstein-Barr virus (EBV): associated nasopharyngeal carcinoma.

Authors:  Yeung Ho; Sai-Wah Tsao; Musheng Zeng; Vivian Wai Yan Lui
Journal:  Cancer Lett       Date:  2012-12-06       Impact factor: 8.679

Review 7.  Gamma interferon blocks gammaherpesvirus reactivation from latency in a cell type-specific manner.

Authors:  Ashley Steed; Thorsten Buch; Ari Waisman; Herbert W Virgin
Journal:  J Virol       Date:  2007-03-14       Impact factor: 5.103

Review 8.  STATs get their move on.

Authors:  Nancy C Reich
Journal:  JAKSTAT       Date:  2013-11-13

9.  Mutational switch of an IL-6 response to an interferon-gamma-like response.

Authors:  Ana P Costa-Pereira; Silvia Tininini; Birgit Strobl; Tonino Alonzi; Joerg F Schlaak; Hayaatun Is'harc; Ida Gesualdo; Sally J Newman; Ian M Kerr; Valeria Poli
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-11       Impact factor: 11.205

10.  A ribonucleoprotein complex protects the interleukin-6 mRNA from degradation by distinct herpesviral endonucleases.

Authors:  Mandy Muller; Stephanie Hutin; Oliver Marigold; Kathy H Li; Al Burlingame; Britt A Glaunsinger
Journal:  PLoS Pathog       Date:  2015-05-12       Impact factor: 6.823

View more
  2 in total

Review 1.  The Role of PARP1 in Monocyte and Macrophage Commitment and Specification: Future Perspectives and Limitations for the Treatment of Monocyte and Macrophage Relevant Diseases with PARP Inhibitors.

Authors:  Maciej Sobczak; Marharyta Zyma; Agnieszka Robaszkiewicz
Journal:  Cells       Date:  2020-09-06       Impact factor: 6.600

2.  Conquering the Host: Determinants of Pathogenesis Learned from Murine Gammaherpesvirus 68.

Authors:  Yiping Wang; Scott A Tibbetts; Laurie T Krug
Journal:  Annu Rev Virol       Date:  2021-09-29       Impact factor: 14.263

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.